Home / Product / Brinzolamide and Brinzolamide Tartrate Ophthalmic Suspension

Brinzolamide and Brinzolamide Tartrate Ophthalmic Suspension

This formulation consists of:

  • Active Ingredients: Brinzolamide & Brimonidine Tartrate
  • Pharmacological grade solvents and excipients

Benefits:

  • Provides dual mechanism of action for lowering intraocular pressure (IOP)
  • Brinzolamide decreases aqueous humor production in the ciliary processes
  • Brimonidine Tartrate reduces aqueous humor secretion and enhances uveoscleral outflow
  • Offers synergistic IOP reduction compared to individual monotherapy
  • Helps prevent optic nerve damage, visual field loss and glaucoma progression
  • Fixed-dose suspension improves patient adherence and reduces drop burden

Available Variations in formulations:

We offer Brinzolamide & Brimonidine Tartrate Ophthalmic Suspension in the following strengths:
  • Brinzolamide 1.0%
  • Brimonidine Tartrate 0.2%

 

Get In Touch

Product Details

Brinzolamide and Brinzolamide Tartrate Ophthalmic Suspension is a fixed-dose combination ophthalmic preparation indicated for the treatment of patients with open-angle glaucoma or ocular hypertension who require multiple medications to achieve target IOP. Brinzolamide lowers intraocular pressure, thereby reducing aqueous humor secretion. Brimonidine Tartrate works by both reducing aqueous humor production and increasing uveoscleral outflow. Together, they provide a complementary and additive effect, ensuring sustained IOP reduction, reducing the risk of optic nerve damage and vision deterioration.

Indications
  • Primary open-angle glaucoma
  • Ocular hypertension
  • Patients requiring combination therapy for IOP control
  • Situations where monotherapy is insufficient
Dosage
  • Adults: Instill 1 drop into the affected eye(s) twice daily, approximately 12 hours apart, or as prescribed by the ophthalmologist.
  • Children: Safety and efficacy in pediatric patients are not well established. Use only under medical supervision.

Uses

N/A

Side Effects

N/A

Packaging Volume

5ml

Minimum Order Quantity

25,000 Units

Delivery Time

45–60 Business Days

Top Categories

Explore our diverse range of pharmaceutical manufacturing categories, designed to deliver high-quality, reliable, and innovative healthcare solutions across multiple dosage forms.

Contact Us

Have any questions?

Phone

Corporate Office
Plot No. :46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India.

Manufacturing Unit
Village Kondi, Post Thana, District Solan, Baddi 173205 Himachal Pradesh, India.

© 2026–2027 Maya Biotech Pvt. Ltd. All Rights Reserved.
get-form

Get in Touch

Looking to elevate your brand with world-class products ? Get in touch with our team for a customized solution.

 

Personal Details

get-form

Get in Touch

Looking to elevate your brand with world-class products ? Get in touch with our team for a customized solution.

 

Personal Details